D. Adams Et Al. , "Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis," NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.1, pp.11-21, 2018
Adams, D. Et Al. 2018. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.1 , 11-21.
Adams, D., Gonzalez-Duarte, A., O'Riordan, W. D., Yang, C. -., Ueda, M., Kristen, A. V., ... Tournev, I.(2018). Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.1, 11-21.
Adams, D. Et Al. "Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis," NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.1, 11-21, 2018
Adams, D. Et Al. "Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis." NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.1, pp.11-21, 2018
Adams, D. Et Al. (2018) . "Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis." NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.1, pp.11-21.
@article{article, author={D. Adams Et Al. }, title={Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2018, pages={11-21} }